A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently disabled in various forms of tumors, resulting uncontrolled https://bookmarkhard.com/story21979773/mini-antibodies-revive-p53-a-promising-approach-for-malignant-management